Ashley Lister

Ashley Lister has had extensive work experience in various pharmaceutical and biotech companies. Ashley is currently the Vice President of Chemistry, Manufacturing, and Controls (CMC) at Amarin Corporation since August 2021. Prior to this role, they served as the Executive Director of CMC at Amarin Corporation from July 2016 to August 2021.

Before joining Amarin Corporation, Ashley worked at Ferring Pharmaceuticals as a Director of Pre-formulation and Analytical Development from October 2013 to July 2016. Ashley also held the position of Senior Director of Analytical R&D at Monosol Rx, LLC from March 2012 to October 2013.

Ashely's earlier experiences include roles at Gilead Sciences as a Director of CMC Regulatory Strategy in January and February 2012, Pharmasset, Inc. as a Director of CMC Regulatory Strategy from March 2010 to January 2012, Amicus Therapeutics as a Director of Pharmaceutical Development/CMC Regulatory from October 2005 to October 2009, and Purdue Pharma where they started their career in 1998 as a Senior/Principal Scientist/Group Leader/Associate Director in Analytical Development and worked until October 2005.

Ashley Lister earned a Bachelor of Science degree in Chemistry from Furman University, from 1989 to 1993. Ashley then pursued a Ph.D. in Analytical Chemistry at Florida State University from 1994 to 1997. Prior to their doctoral studies, Ashley attended the University of Cincinnati in 1993, but did not complete a degree at that time.